Clinical Trials Browser

Terminated × avelumab × Other hematologic neoplasm × Clear all

NCT02953561 2020-10-22

Avelumab and Azacitidine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia

Phase 1/2 Terminated

19 enrolled 11 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03395873 2019-08-21

Avelumab With Decitabine as First Line for AML Treatment of Patients With AML, Who Are Unfit for Intensive Chemotherapy

Phase 1 Terminated

Other hematologic neoplasm

Leukemia, Myeloid, Acute